公开(公告)号：US20230357145A1

公开(公告)日：2023-11-09

申请号：US18218216

申请日：2023-07-05

Applicant: Enveric Biosciences Canada Inc.

Inventor： Jillian M. Hagel ,  Ye Cai ,  Kaveh Matinkhoo ,  David James Press ,  Glynnis Elizabeth Jensen ,  Peter J. Facchini

IPC: C07D209/16

CPC classification number: C07D209/16

Abstract: Disclosed are novel C4-carboxylic acid-substituted tryptamine derivative compounds and pharmaceutical and recreational drug formulations containing the same. The pharmaceutical formulations may be used to treat brain neurological disorders.

公开(公告)号：US11707447B1

公开(公告)日：2023-07-25

申请号：US17893122

申请日：2022-08-22

Applicant: Enveric Biosciences Canada Inc.

Inventor： Jillian M. Hagel ,  Kaveh Matinkhoo ,  Peter J. Facchini

IPC: A61K31/4045 ,  C07D209/16 ,  A61P25/00 ,  C07D209/20

CPC classification number: A61K31/4045 ,  A61P25/00 ,  C07D209/20 ,  C07D209/16

Abstract: Disclosed are novel C4-carbonothioate-substituted tryptamine derivative compounds and pharmaceutical and recreational drug formulations containing the same. The pharmaceutical formulations may be used to treat brain neurological disorders.

公开(公告)号：US12195439B1

公开(公告)日：2025-01-14

申请号：US18494382

申请日：2023-10-25

Applicant: Enveric Biosciences Canada Inc.

Inventor： Kaveh Matinkhoo ,  David James Press ,  Glynnis Elizabeth Jensen ,  Jillian M. Hagel ,  Peter J. Facchini

IPC: C07D317/58 ,  A61P25/00 ,  C07D319/18 ,  C07D405/06

Abstract: Disclosed are novel fused mescaline derivative compounds, notably C1-substituted isopropylamine fused heterocyclic mescaline derivatives, including C1-substituted isopropylamine fused dioxolane and fused dioxane mescaline derivatives, and pharmaceutical and recreational drug formulations containing the same. Methods of making and using these compounds are also disclosed.

公开(公告)号：US11845726B2

公开(公告)日：2023-12-19

申请号：US17893113

申请日：2022-08-22

Applicant: Enveric Biosciences Canada Inc.

Inventor： Jillian M. Hagel ,  Kaveh Matinkhoo ,  Peter J. Facchini

IPC: C07D209/16

CPC classification number: C07D209/16

Abstract: Disclosed are novel C4-carbonothioate-substituted tryptamine derivative compounds and pharmaceutical and recreational drug formulations containing the same. The pharmaceutical formulations may be used to treat brain neurological disorders.

公开(公告)号：US20230295085A1

公开(公告)日：2023-09-21

申请号：US17893113

申请日：2022-08-22

Applicant: Enveric Biosciences Canada Inc.

Inventor： Jillian M. Hagel ,  Kaveh Matinkhoo ,  Peter J. Facchini

IPC: C07D209/16

CPC classification number: C07D209/16

Abstract: Disclosed are novel C4-carbonothioate-substituted tryptamine derivative compounds and pharmaceutical and recreational drug formulations containing the same. The pharmaceutical formulations may be used to treat brain neurological disorders.

公开(公告)号：US11746087B1

公开(公告)日：2023-09-05

申请号：US17885978

申请日：2022-08-11

Applicant: Enveric Biosciences Canada Inc.

Inventor： Jillian M. Hagel ,  Ye Cai ,  Kaveh Matinkhoo ,  David James Press ,  Glynnis Elizabeth Jensen ,  Peter J. Facchini

IPC: C07D209/16

CPC classification number: C07D209/16

Abstract: Disclosed are novel C4-carboxylic acid-substituted tryptamine derivative compounds and pharmaceutical and recreational drug formulations containing the same. The pharmaceutical formulations may be used to treat brain neurological disorders.